Meet our Hypertrophic Cardiomyopathy team, led by Program Director Dr. Sabahat Bokhari.
(New Brunswick, NJ) – Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical School (RWJMS), has been designated as a Hypertrophic Cardiomyopathy Association (HCMA) Recognized Center of Excellence (COE) by the Hypertrophic Cardiomyopathy Association. This recognition acknowledges the hospital’s expertise in delivering comprehensive, multidisciplinary care for patients living with this complex heart condition. RWJUH is part of the RWJBarnabas Health Heart and Vascular network of care.
The HCMA is the nation’s leading patient advocacy organization dedicated to improving the lives of individuals with hypertrophic cardiomyopathy through education, research, and the development of standards for high-quality HCM care.
To qualify as an HCMA Recognized COE, a program must demonstrate that it provides high-quality care to HCM patients in accordance with direct care guidelines. All COEs undergo a rigorous evaluation by the HCMA in the following areas: expertise, volume of care, quality of research, patient communication and responsiveness, patient and medical education, and the quality of their facilities (which includes access to advanced cardiac imaging capabilities).
"RWJUH’s designation as an HCMA Recognized Center of Excellence underscores our hospital and RWJBarnabas Health’s commitment to advancing cardiovascular care and improving outcomes for patients living with this serious condition,” said RWJUH President Alan Lee. "Achieving this designation reflects the exceptional work of our physicians, nurses, and care teams, and assures patients that they have access to nationally recognized expertise, innovative therapies, and comprehensive care to effectively manage their disease."
“As a New Jersey resident with HCM, I am excited to see Robert Wood Johnson University Hospital bring additional high-quality HCM care to my home state,” said Lisa Salberg, CEO & Founder of HCMA.
"For patients, receiving care at a HCMA Recognized Center of Excellence means having access to a highly experienced, multidisciplinary team dedicated to every aspect of this complex disease,” explains Sabahat Bokhari, MD, FACC, FASNC, Director, Hypertrophic Cardiomyopathy Center of Excellence, New Jersey Rare Disorders Center of Excellence, Amyloidosis Center of Excellence and Advanced Cardiac Imaging Center, RWJUH, and Professor of Medicine and Program Director, Advanced Cardiac Imaging Fellowship Program, RWJMS. “A Center of Excellence recognition gives patients and families confidence that they can benefit from leading-edge treatments and technologies, clinical trials, personalized care plans, and critical ongoing support close to home to achieve the best possible outcomes."
For more information, please visit: https://www.4hcm.org/COE/RWJ
Learn more about Hypertrophic Cardiomyopathy (HCM)
About Robert Wood Johnson University Hospital
Robert Wood Johnson University Hospital (RWJUH), a RWJBarnabas Health Facility, is a 724-bed academic medical center in New Brunswick that is New Jersey’s largest academic medical center through its deep partnership with Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute. RWJUH is home to the Jack & Sheryl Morris Cancer Center and The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital, a nationally-ranked 2026-27 Best Children’s Hospital by U.S. News & World Report. RWJUH is recognized by U.S. News & World Report as a Best Regional Hospital for 2026-2027 with 10 High Performing Adult Specialties and Conditions. Centers of Excellence include heart and vascular care from minimally invasive heart surgery to transplantation, cancer care, stroke care, neuroscience, orthopedics, pediatrics and women’s health. As the only state-designated Adult Level 1 Trauma Center with an ACS COT Level I-verified Pediatric Trauma Center in New Jersey, RWJUH serves as a national resource in its ground-breaking approaches to emergency preparedness.
For more Information visit us online at www.rwjbh.org/newbrunswick
About the Hypertrophic Cardiomyopathy Association
The Hypertrophic Cardiomyopathy Association, HCMA, was founded in 1996 as an international resource for patients, families, and the medical community on matters of importance. HCM is a genetic heart muscle disorder affecting 1 in 250 people worldwide. The HCMA provides services to enhance understanding, provide support, foster research, ensure high-quality health care, and support public policies of importance. The HCMA is a 501c(3) with offices in Denville, NJ, and online at www.4hcm.org
Contact: Peter Haigney
RWJUH Public Relations
(732) 937-8568